PDF herunterladen
CC BY-NC-ND 4.0 · Endoscopy 2023; 11(11): E1092-E1098
DOI: 10.1055/a-2185-5947
Original article

Pilot study of an endoluminal-suturing device as a treatment for patients with gastroesophageal reflux disease

Hubert Louis
1   Gastroenterology, Hepatopancreatology and Digestive Oncology, Hôpital Universitaire de Bruxelles (H.U.B.), C.U.B. Hôpital Erasme, Université Libre de Bruxelles, Bruxelles, Belgium
,
Pauline Van Ouytsel
1   Gastroenterology, Hepatopancreatology and Digestive Oncology, Hôpital Universitaire de Bruxelles (H.U.B.), C.U.B. Hôpital Erasme, Université Libre de Bruxelles, Bruxelles, Belgium
,
Loulia Leclercq
2   Endo Tools Therapeutics, Gosselies, Belgium
,
Mélina Houinsou Hans
3   Department of Biomedical Research, Université Libre de Bruxelles, Bruxelles, Belgium (Ringgold ID: RIN26659)
,
Jacques Devière
1   Gastroenterology, Hepatopancreatology and Digestive Oncology, Hôpital Universitaire de Bruxelles (H.U.B.), C.U.B. Hôpital Erasme, Université Libre de Bruxelles, Bruxelles, Belgium
,
Ricardo Rio-Tinto
4   Digestive Diseases Unit, Champalimaud Foundation, Lisboa, Portugal (Ringgold ID: RIN247170)
,
Vincent Huberty 
1   Gastroenterology, Hepatopancreatology and Digestive Oncology, Hôpital Universitaire de Bruxelles (H.U.B.), C.U.B. Hôpital Erasme, Université Libre de Bruxelles, Bruxelles, Belgium
› Institutsangaben TRIAL REGISTRATION: Registration number (trial ID): NCT03999502, Trial registry: ClinicalTrials.gov (http://www.clinicaltrials.gov/), Type of Study: Prospective
› Weitere Informationen
Auch verfügbar auf
  Lizenzen und Reprints

Abstract

Background and study aims Endoscopic therapy is a promising option for patients with gastroesophageal reflux disease (GERD). The aim of this study was to assess safety and feasibility of the Endomina suturing platform as a treatment for GERD.

Patients and methods This was a two-center study of patients with chronic GERD symptoms that responded at least partially to proton pump inhibitors (PPIs). Primary endpoints were to assess the safety of the procedure and persistence of the sutures. Secondary endpoints were to assess esophageal pH-impedance and manometry parameters changes at 6 months, as well as GERD symptoms and PPI use up to 12 months of follow-up.

Results Fourteen patients were treated (13 males, mean of 43±12 years), with a mean number of three plications per patient. Thirteen, 10, and nine patients were analyzed at 3, 6, and 12 months of follow-up, respectively. One device-related adverse event occurred (loss of needle tip requiring endoscopic retrieval 1 week later). A mean of two plications persisted at 3 and 12 months. A decrease in median acid exposure time and reflux episodes was observed after the procedure. Mean Reflux Symptom Index and GERD-Health-Related Quality of Life scores decreased during follow-up visits and 90% of the patients discontinued PPI use at 1 year.

Conclusions Endoscopic full-thickness suturing of the esophagogastric junction with the Endomina suturing platform is feasible, allowing persistence of two-thirds of the plications, with promising results for decreasing reflux and improving GERD symptoms.

Keywords

GERD - endoscopic treatment - endoscopic suturing device


Publikationsverlauf

Eingereicht: 11. April 2023

Angenommen nach Revision: 22. September 2023

Accepted Manuscript online:
04. Oktober 2023

Artikel online veröffentlicht:
27. November 2023

© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

Kommentar zu diesem Artikel:

Endoscopy International Open – recently publishedEndoscopy 2024; 56(02): 162-162
DOI: 10.1055/a-2209-3193

 

  • References

  • 1 Bredenoord AJ, Pandolfino JE, Smout AJ. Gastro-esophageal reflux disease. Lancet 2013; 381: 1933-1942
    CrossrefPubMedSuche in Google Scholar
  • 2 Subramanian CR, Triadafilopoulos G. Refractory gastroesophageal reflux disease. Gastroenterol Rep (Oxf) 2015; 3: 41-53
    CrossrefPubMedSuche in Google Scholar
  • 3 Herregods TV, Bredenoord AJ, Smout AJ. Pathophysiology of gastroesophageal reflux disease: new understanding in a new era. Neurogastroenterol Motil 2015; 27: 1202-1213
    CrossrefPubMedSuche in Google Scholar
  • 4 Oelschlager BK. et al. Long-term outcomes after laparoscopic antireflux surgery. Am J Gastroenterol 2008; 103: 280-288
    CrossrefPubMedSuche in Google Scholar
  • 5 Galmiche JP, Hatlebakk J, Attwood S. et al. Laparoscopic antireflux surgery vs esomeprazole treatment for chronic GERD: the LOTUS randomized clinical trial. JAMA 2011; 305: 1969-1977
    CrossrefPubMedSuche in Google Scholar
  • 6 Vakil N, Shaw M, Kirby R. Clinical effectiveness of laparoscopic fundoplication in a US community. Am J Med 2003; 114: 1-5
    CrossrefPubMedSuche in Google Scholar
  • 7 Richter JE. Gastroesophageal reflux disease treatment: side effects and complications of fundoplication. Clin Gastroenterol Hepatol 2013; 11: 465-471
    CrossrefPubMedSuche in Google Scholar
  • 8 Rothstein R, Filipi C, Caca K. et al. Endoscopic full-thickness plication for the treatment of gastroesophageal reflux disease: A randomized, sham-controlled trial. Gastroenterology 2006; 131: 704-712
    CrossrefPubMedSuche in Google Scholar
  • 9 Muls V, Eckardt AJ, Marchese M. et al. Three-year results of a multicenter prospective study of transoral incisionless fundoplication. Surg Innov 2013; 20: 321-330
    CrossrefPubMedSuche in Google Scholar
  • 10 Witteman BP, Strijkers R, de Vries E. et al. Transoral incisionless fundoplication for treatment of gastroesophageal reflux disease in clinical practice. Surg Endosc 2012; 26: 3307-3315
    CrossrefPubMedSuche in Google Scholar
  • 11 Huberty V, Ibrahim M, Hiernaux M. et al. Safety and feasibility of an endoluminal-suturing device for endoscopic gastric reduction (with video). Gastrointest Endosc 2017; 85: 833-837
    CrossrefPubMedSuche in Google Scholar
  • 12 Huberty V, Boskoski I, Bove V. et al. Endoscopic sutured gastroplasty in addition to lifestyle modification: short-term efficacy in a controlled randomised trial. Gut 2020; 322026
    CrossrefPubMedSuche in Google Scholar
  • 13 Raphael KL, Walsh P, Benias PC. Innovations in endoscopic therapy for gastroesophageal reflux disease. Gastrointest Endosc Clin N Am 2020; 30: 291-307
    CrossrefPubMedSuche in Google Scholar
  • 14 Schiefke I, Zabel-Langhennig A, Neumann S. et al. Long term failure of endoscopic gastroplication (EndoCinch). Gut 2005; 54: 752-758
    CrossrefPubMedSuche in Google Scholar
  • 15 Thosani N, Goodman A. ASGE Technology Committee. et al. Endoscopic anti-reflux devices (with videos). Gastrointest Endosc 2017; 86: 931-948
    CrossrefPubMedSuche in Google Scholar
  • 16 Kushner BS, Awad MM, Mikami DJ. et al. Endoscopic treatments for GERD. Ann N Y Acad Sci 2020; 1482: 121-129
    CrossrefPubMedSuche in Google Scholar